Drug Detection Panel, Umbilical Cord Tissue, Qualitative
Use
Detection of drugs in umbilical cord tissue is intended to reflect maternal drug use during approximately the last trimester of a full-term pregnancy. The test does not determine the pattern and frequency of drug use nor does a negative result exclude the possibility of drug use. Detection depends on extent of usage, drug stability, and specific deposition characteristics in umbilical cord tissue. Drugs administered during labor may also be detected. This test is for medical purposes only and is not valid for forensic use.
Special Instructions
Not provided.
Limitations
The test cannot determine the pattern and frequency of maternal drug use and a negative result does not exclude the possibility of drug use. It is dependent on the extent of maternal drug use, drug stability, unique characteristics of drug deposition, and performance of the analytical method. Detection of drugs does not insinuate impairment or affect outcomes for the infant.
Methodology
Mass Spectrometry
Biomarkers
LOINC Codes
- 62364-5 - Test performance info Spec
- 82373-2 - Buprenorphine Spec Ql Scn
- 40626-4 - Codeine Spec Ql
- 97242-2 - DHC+Hydrocodol Free TissCo Ql Scn
- 61042-8 - fentaNYL Spec Ql
- 32080-4 - HYDROcodone Spec Ql
- 32081-2 - HYDROmorphone Spec Ql
- 32088-7 - Meperidine Spec Ql
- 32093-7 - Methadone Spec Ql
- 41859-0 - EDDP Spec Ql
- 32099-4 - 6MAM Spec Ql
- 32100-0 - Morphine Spec Ql
- 100357-3 - Naloxone TissCo Ql Scn
- 32101-8 - oxyCODONE Spec Ql
- 91053-9 - oxyCODONE+oxyMORphone Tiss Ql Scn
- 43811-9 - Propoxyph Spec Ql
- 59355-8 - Tapentadol Tiss-mCnt
- 97306-5 - traMADol TissCo Ql Scn
- 97292-7 - O-nortramadol TissCo Ql Scn
- 29530-3 - Amphetamines Spec Ql
- 40609-0 - BZE Spec Ql
- 43230-2 - BZE Spec-mCnc
- 48946-8 - Cocaethylene Spec-mCnc
- 40625-6 - Cocaine Spec Ql
- 40481-4 - MDMA Spec Ql
- 40381-6 - Methamphet Spec Ql
- 100358-1 - Phentermine TissCo Ql Scn
- 61038-6 - Alpraz Spec Ql
- 61037-8 - A-OH Alpraz Spec Ql
- 32057-2 - Butalbital Spec Ql
- 61039-4 - clonazePAM Spec Ql
- 61031-1 - 7Aminoclonazepam Spec Ql
- 61074-1 - diazePAM Spec Ql
- 61044-4 - LORazepam Spec Ql
- 59712-0 - Midazolam Tiss-mCnt
- 97278-6 - Midazolam TissCo Ql Scn
- 61051-9 - Nordiazepam Spec Ql
- 61055-0 - Oxazepam Spec Ql
- 32108-3 - Phenobarb Spec Ql
- 61061-8 - Temazepam Spec Ql
- 97310-7 - Zolpidem TissCo Ql Scn
- 32107-5 - PCP Spec Ql
- 93121-2 - Gabapentin Tiss Ql Scn
- 82375-7 - Norbuprenorphine Spec Ql Scn
- 97286-9 - Norhydrocodone TissCo Ql Scn
- 97290-1 - Noroxycodone TissCo Ql Scn
- 97296-8 - oxyMORphone Free TissCo Ql Scn
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Tissue (Unknown)
Volume
Not provided
Minimum Volume
Not provided
Container
Routine urine collection cup or Security Kit for Meconium/Umbilical Drug Detection
Collection Instructions
Drain and discard any blood from the umbilical cord. Rinse the exterior with normal saline or water, pat dry, and transport at least 8 inches of umbilical cord.
Causes for Rejection
Cords soaking in blood or other fluid. Formalin-fixed tissue. Tissue that is obviously decomposed.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 1 week |
| Refrigerated | 3 weeks |
| Frozen | 1 year |
Other tests from different labs that may be relevant
